Advertisement

Topics

Oxford Expression Technologies Company Profile

21:27 EDT 23rd September 2018 | BioPortfolio

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutical companies and are now marketing commercial products based upon our world-beating flashBAC protein expression technologyOET was founded in 2000 by leading members of the School of Biological and Molecular Science at Oxford Brookes University and of NERC CEH Oxford. Our mission is to exploit innovative developments in the baculovirus protein expression system that have established the two institutes at the forefront of this technology.

Location

Oxford Brookes UniversityGypsy Lane Campus
Headington
Oxfordshire
OX3 0BP
United Kingdom

Contact

Fax: (+44) 01865 483250
Email: info@expressiontechnologies.com


News Articles [963 Associated News Articles listed on BioPortfolio]

#jobs #lifescience OMass Technologies: Protein Biochemist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: OMass Technologies: Protein Biochemist . Comptitive: OMass Technologies: OMas...

DNA Sequencing Unicorn Oxford Nanopore Raises £100M round at £1.5B valuation

Undeterred by competitors, Oxford Nanopore Technologies, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next generation sequencing platform...

Oxford Nanopore Completes $140 Million Funding Led by Asian Investors

Oxford Nanopore Technologies, a UK company that offers several portable real-time DNA/RNA sequencers, completed a $140 million funding led by Asian investors. The investors were GIC (the Singapore sov...

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company...

Nitric Oxide conference gets under way in Oxford

Delegates from round the world have descended on Oxford for the 10th international conference of the Nitric Oxide Society, which has got under way. This year, the NIHR oxford Biomedical Research Centr...

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has s...

This Oxford Biotech is Using mRNA to Find New Peptide Drugs

Today, we’re in Oxford, UK, visiting Orbit Discovery. The biotech develops peptide drugs for chronic diseases using mRNA display technologies by linking proteins to their encoding DNA. Mission:...

Oxford woman sheds nearly six stone after diabetes diagnosis – Oxford Mail

Oxford MailOxford woman sheds nearly six stone after diabetes diagnosisOxford MailA DIABETES diagnosis was a wake-up call for one Oxford woman who has now shed nearly six stone. 0 comment. Retired nur...

PubMed Articles [3320 Associated PubMed Articles listed on BioPortfolio]

IDP-denovo: de novo transcriptome assembly and isoform annotation by hybrid sequencing.

In the past years, the long read (LR) sequencing technologies, such as Pacific Biosciences and Oxford Nanopore Technologies, have been demonstrated to substantially improve the quality of genome assem...

NanoPack: visualizing and processing long read sequencing data.

Here we describe NanoPack, a set of tools developed for visualization and processing of long read sequencing data from Oxford Nanopore Technologies and Pacific Biosciences.

MinIONQC: fast and simple quality control for MinION sequencing data.

MinIONQC provides rapid diagnostic plots and quality control data from one or more flowcells of sequencing data from Oxford Nanopore Technologies' MinION instrument. It can be used to assist with the ...

BrainEXP: a database featuring with spatiotemporal expression variations and co-expression organizations in human brains.

Gene expression changes over the lifespan and varies among different tissues or cell types. Gene co-expression also changes by sex, age, different tissues or cell types. However, gene expression under...

Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment.

To investigate the expression of IL-18 in symptomatic and asymptomatic muscle tissues of patients with PM and DM and the effects of conventional immunosuppressive treatment on such expression.

Clinical Trials [2045 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [1633 Associated Companies listed on BioPortfolio]

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

Oxford Nanopore Technologies Ltd

Oxford Nanopore Technologies Ltd is developing a revolutionary technology for direct, electrical detection and analysis of single molecules. The platform is designed to offe...

Oxford Nanopore Technologies Ltd.

Oxford Nanopore Technologies Ltd is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable GridI...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

More Information about "Oxford Expression Technologies" on BioPortfolio

We have published hundreds of Oxford Expression Technologies news stories on BioPortfolio along with dozens of Oxford Expression Technologies Clinical Trials and PubMed Articles about Oxford Expression Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Expression Technologies Companies in our database. You can also find out about relevant Oxford Expression Technologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record